Stanford University: Depressive Disorder trials

The registry lists 53 Depressive Disorder studies with Stanford University as lead sponsor. 2 are open to participants now and 19 have results posted.

Early Phase 1 2Phase 1 1Phase 2 5Phase 3 4Phase 4 5No phase 38(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingNot yet recruitingNCT06748950Not applicable
• Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of DepressionNot yet recruitingNCT04730180Not applicable
• Virtual Reality Behavioral Activation: An Intervention for Major Depressive DisorderCompletedNCT04268316Not applicableResults posted
• The BIomarker Guided (BIG) Study for DepressionCompletedNCT04181736Phase 4Results posted
• Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac SurgeryCompletedNCT03861988Phase 4Results posted
• iTBS in Refractory Pediatric DepressionTerminatedNCT03845504Not applicableResults posted
• Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in VeteransTerminatedNCT03291431Not applicableResults posted
• Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL CohortCompletedNCT03240692Not applicableResults posted
• Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)CompletedNCT03068715Not applicableResults posted
• Brain Imaging of rTMS Treatment for DepressionCompletedNCT01829165Not applicableResults posted
• Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
• Functional MRI Before and After Treatment for DepressionTerminatedNCT00896441Not applicableResults posted
• Treatment of Psychotic Major Depression With MifepristoneTerminatedNCT00867360Phase 3Results posted
• TRIAD - Treatment of Insomnia and DepressionCompletedNCT00767624Phase 2/3Results posted
• Treatment of Schizoaffective Disorder Using MifepristoneTerminatedNCT00725270Phase 2/3Results posted
• Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECTCompletedNCT00285818Not applicableResults posted
• Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major DepressionCompletedNCT00186498Not applicableResults posted
• Treatment of Nicotine Dependence and Acute DepressionCompletedNCT00186446Phase 4Results posted
• Depakote ER in Bipolar DepressionCompletedNCT00186186Phase 4Results posted
• Mifepristone in Refractory DepressionCompletedNCT00186056Not applicableResults posted
• Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression OutcomeCompletedNCT00149825Phase 2Results posted
• Open Label - Personalized Therapeutic Neuromodulation for Anhedonic DepressionActive, not recruitingNCT06052137Not applicable
• Treatment for Cognitive Impairment in DepressionWithdrawnNCT04317001Phase 3
• SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following ArthroplastyWithdrawnNCT04195308Not applicable
• Epinephrine and Cortisol in DepressionWithdrawnNCT04148261Early Phase 1
• rTMS Study in Depression to Evaluate the Relationship Between Brain Plasticity and Clinical OutcomeWithdrawnNCT04032015Not applicable
• aTBS for Treatment of Depression in AUDWithdrawnNCT03981185Not applicable
• Accelerated Intermittent Theta-Burst Stimulation for Opiate Use DisorderWithdrawnNCT03804619Not applicable
• RCT of Automated Conversational Agent vs. Treatment as Usual for the Management of Perinatal MoodCompletedNCT03646539Not applicable
• Precision Psychiatry Continuity Clinic ProjectCompletedNCT03260985Not applicable
• MRS and Medication Response: A Pilot StudyTerminatedNCT03254342
• Objective Evaluation of Depression Using Sleep EEGCompletedNCT03133013Not applicable
• Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)CompletedNCT02911597Phase 1
• Brain-Based Biomarkers in Response to TMS in MDDCompletedNCT02843373
• The Effect of Cortisol Administration on Neural Correlates of Emotion in DepressionCompletedNCT02837432Early Phase 1
• Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic IllnessCompletedNCT02453880Not applicable
• Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression SymptomsTerminatedNCT02449499
• A Brief Behavioral Sleep Intervention for Depression Among Military VeteransCompletedNCT01958541Not applicable
• Identifying Biological Markers for Severe DepressionCompletedNCT01831882
• Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive DisorderWithdrawnNCT01733654Phase 2
• A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the LifespanCompletedNCT01616797Not applicable
• Mothers With a History of Depression and Their 10-14 Year Old DaughtersCompletedNCT01129752
• Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
• Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
• Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
• Mild Depression 2 Week Observational StudyCompletedNCT00285831
• Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic SettingCompletedNCT00285740Not applicable
• Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major DepressionCompletedNCT00285727Not applicable
• Genetics of Recurrent Early Onset Major DepressionCompletedNCT00260182
• Acupuncture and Massage for Depression During PregnancyCompletedNCT00186654Phase 2
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?CompletedNCT00186264Not applicable
• Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
• Genetics of Recurrent Early-Onset DepressionCompletedNCT00005914